Precigen, Inc. (PGEN) Reports Q3 Loss, Lags Revenue Estimates
Portfolio Pulse from
Precigen, Inc. (PGEN) reported a Q3 loss of $0.09 per share, missing the Zacks Consensus Estimate of a $0.08 loss. This is a slight increase in loss compared to the $0.08 per share loss from the previous year.
November 15, 2024 | 12:00 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Precigen, Inc. reported a Q3 loss of $0.09 per share, which was worse than the expected $0.08 loss. This marks a slight increase in loss from the previous year.
The reported loss per share of $0.09 was worse than the consensus estimate of $0.08, indicating a negative surprise for investors. This could lead to a short-term negative impact on the stock price as it reflects underperformance compared to expectations.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100